Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance / Mariottini A, Repice AM, Barilaro A, Massacesi L. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-3478. - ELETTRONICO. - 43:(2022), pp. 4095-4097.
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
Mariottini A
;Repice AM;Barilaro A;Massacesi L
2022
Abstract
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Anti‑SARS‑Cov2 vaccination at the time of the COVID‑19 pandemic.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
538.17 kB
Formato
Adobe PDF
|
538.17 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
